07:00 , Oct 24, 2016 |  BioCentury  |  Finance

Sofinnova steps up

With fewer crossover investors participating in its private biotech financings, Sofinnova Ventures has raised a new $650 million fund that will allow it to invest more capital per company to see them through key milestones....
07:00 , May 22, 2006 |  BioCentury  |  Finance

Ebb & Flow

By all accounts, last week was a banner week on the venture side. A total of $175.4 million was raised by private biotechs, which far exceeded the industry’s average of about $100 million per week...
01:19 , May 17, 2006 |  BC Extra  |  Financial News

Intercept raises $41 million

Intercept (New York, N.Y.) raised $41 million in an undisclosed venture round led by Genextra. Balyasny Asset Management and JAFCO also participated in the round. Riverbank Capital Securities and Rodman were placement agents. Genextra CFO...